We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BA icon
101
Boeing
BA
$175B
$2.79M 0.28%
21,890
+6,500
+42% +$849K
KRC icon
102
Kilroy Realty
KRC
$4.5B
$2.68M 0.27%
43,000
-6,200
-13% -$374K
FRT icon
103
Federal Realty Investment Trust
FRT
$10.9B
$2.67M 0.27%
22,070
– –
MMM icon
104
3M
MMM
$94.1B
$2.65M 0.27%
22,138
+5,621
+34% +$660K
ARE icon
105
Alexandria Real Estate Equities
ARE
$9.41B
$2.64M 0.27%
34,040
– –
AXP icon
106
American Express
AXP
$227B
$2.64M 0.27%
27,860
+4,597
+20% +$414K
ABBV icon
107
AbbVie
ABBV
$465B
$2.64M 0.27%
46,709
+14,800
+46% +$776K
TCO
108
DELISTED
Taubman Centers Inc.
TCO
$2.63M 0.27%
34,700
-550
-2% -$40.5K
GE icon
109
GE Aerospace
GE
$377B
$2.6M 0.26%
20,683
-25,755
-55% -$3.28M
AUXL
110
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$2.58M 0.26%
128,671
+15,450
+14% +$354K
MO icon
111
Altria Group
MO
$125B
$2.58M 0.26%
61,450
+22,200
+57% +$893K
CVX icon
112
Chevron
CVX
$374B
$2.57M 0.26%
19,700
-22,808
-54% -$2.84M
MAC icon
113
Macerich
MAC
$7.52B
$2.52M 0.26%
37,794
– –
WFC icon
114
Wells Fargo
WFC
$263B
$2.52M 0.26%
48,005
-55,483
-54% -$2.79M
ROSE
115
DELISTED
ROSETTA RESOURCES INC
ROSE
$2.52M 0.26%
45,938
+39,690
+635% +$1.93M
AMGN icon
116
Amgen
AMGN
$212B
$2.45M 0.25%
20,684
+5,800
+39% +$671K
HOT
117
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$2.44M 0.25%
30,130
+2,000
+7% +$157K
NEM icon
118
Newmont
NEM
$96.4B
$2.35M 0.24%
92,570
+80,500
+667% +$1.94M
BP icon
119
BP
BP
$107B
$2.35M 0.24%
54,552
-14,191
-21% -$585K
BIIB icon
120
Biogen
BIIB
$30.4B
$2.33M 0.24%
7,400
+654
+10% +$197K
CNMD icon
121
CONMED
CNMD
$1.33B
$2.33M 0.24%
+52,674
New +$2.39M
CVC
122
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$2.3M 0.23%
130,441
-52,777
-29% -$902K
PG icon
123
Procter & Gamble
PG
$347B
$2.27M 0.23%
28,906
-23,300
-45% -$1.88M
UPS icon
124
United Parcel Service
UPS
$89.7B
$2.25M 0.23%
21,950
+240
+1% +$24.1K
CELG
125
DELISTED
Celgene Corp
CELG
$2.23M 0.23%
25,966
+6,310
+32% +$480K
3 4
5
6 7

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.